UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions

Gynecologic oncology, 2015-01, Vol.136 (1), p.3-7

2015

Volltextzugriff (PDF)

Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer

Cancer, 2015-07, Vol.121 (13), p.2108-2120

2015

Volltextzugriff (PDF)

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper

Gynecologic oncology, 2017-08, Vol.146 (2), p.217-224

2017

Volltextzugriff (PDF)

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

The Lancet (British edition), 2010-07, Vol.376 (9737), p.245-251

2010

Volltextzugriff (PDF)

Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy

Journal of clinical oncology, 2005-01, Vol.23 (1), p.127-132

2005

Volltextzugriff (PDF)

Impact of body mass index on ovarian cancer survival varies by stage

British journal of cancer, 2017-07, Vol.117 (2), p.282-289

2017

Volltextzugriff (PDF)

Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer

Gynecologic oncology reports, 2022-02, Vol.39, p.100899-100899, Article 100899

2022

Volltextzugriff (PDF)

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions

Gynecologic oncology, 2007-11, Vol.107 (2), p.159-162

2007

Volltextzugriff (PDF)

Cost Savings of Population Based Genetic Testing among Ashkenazi Jewish Adult Females in Northern California

Gynecologic oncology, 2016-10, Vol.143 (1), p.195-196

2016

Volltextzugriff (PDF)

Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index

JAMA oncology, 2015-09, Vol.1 (6), p.737

2015

Volltextzugriff (PDF)

Risk reducing salpingo-oophorectomy for BRCA mutation carriers: Twenty years later

Gynecologic oncology, 2014-02, Vol.132 (2), p.261-263

Powell, C. Bethan

2014

Volltextzugriff (PDF)

Clinical Outcomes and Prognostic Markers in Uterine Leiomyosarcoma: A Population-Based Cohort

International journal of gynecological cancer, 2015-05, Vol.25 (4), p.622-628

2015

Volltextzugriff (PDF)

Classification of postoperative complications in robotic-assisted compared with laparoscopic hysterectomy for endometrial cancer

Journal of minimally invasive gynecology, 2016-11, Vol.23 (7), p.1181-1188

2016

Volltextzugriff (PDF)

Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival

Clinical cancer research, 2016-12, Vol.22 (23), p.5909-5914

2016

Volltextzugriff (PDF)

Surveillance of survivors: Follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers

Gynecologic oncology, 2011-08, Vol.122 (2), p.339-343

2011

Volltextzugriff (PDF)

Salpingectomy for Sterilization: Change in Practice in a Large Integrated Health Care System, 2011-2016

Obstetrics and gynecology (New York. 1953), 2017-11, Vol.130 (5), p.961-967

2017

Volltextzugriff (PDF)

Does Surgical Teaching Take Time? Resident Participation in Minimally Invasive Hysterectomy for Endometrial Cancer

Journal of minimally invasive gynecology, 2017-07, Vol.24 (5), p.783-789

2017

Volltextzugriff (PDF)

Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer

Gynecologic oncology, 2005-02, Vol.96 (2), p.301-306

2005

Volltextzugriff (PDF)

Corrigendum to “Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions” [Gynecol. Oncol. 136 (2015) 3–7]

Gynecologic oncology, 2015-09, Vol.138 (3), p.765-765

2015

Volltextzugriff (PDF)

Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system

Gynecologic oncology, 2022-12, Vol.167 (3), p.467-475

2022

Volltextzugriff (PDF)

PIK3CA is implicated as an oncogene in ovarian cancer

Nature genetics, 1999-01, Vol.21 (1), p.99-102

1999

Volltextzugriff (PDF)

Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system

Gynecologic oncology, 2021-10, Vol.163 (1), p.134-141

2021

Volltextzugriff (PDF)

Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations

Gynecologic oncology, 2018-12, Vol.151 (3), p.489-493

2018

Volltextzugriff (PDF)

Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations

Gynecologic oncology, 2019-08, Vol.154 (2), p.374-378

2019

Volltextzugriff (PDF)

Risk management options elected by women after testing positive for a BRCA mutation

Gynecologic oncology, 2014-02, Vol.132 (2), p.428-433

2014

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(141)

Sprache

Englisch
(141)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(95)
Humans
(76)
Female
(75)
Oncology
(57)
Obstetrics & Gynecology
(50)
Middle Aged
(40)
Adult
(32)
Aged
(24)
Obstetrics And Gynecology
(23)
Ovarian Neoplasms - Genetics
(23)
Biological And Medical Sciences
(22)
Medical Sciences
(21)
Hematology, Oncology And Palliative Medicine
(20)
Ovarian Cancer
(20)
Retrospective Studies
(16)
Genes, Brca1
(15)
Genes, Brca2
(14)
Ovarian Neoplasms - Pathology
(14)
Genetic Predisposition To Disease
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions

Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy

Impact of body mass index on ovarian cancer survival varies by stage

Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions

Cost Savings of Population Based Genetic Testing among Ashkenazi Jewish Adult Females in Northern California

Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index

Risk reducing salpingo-oophorectomy for BRCA mutation carriers: Twenty years later

Clinical Outcomes and Prognostic Markers in Uterine Leiomyosarcoma: A Population-Based Cohort

Classification of postoperative complications in robotic-assisted compared with laparoscopic hysterectomy for endometrial cancer

Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival

Surveillance of survivors: Follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers

Salpingectomy for Sterilization: Change in Practice in a Large Integrated Health Care System, 2011-2016

Does Surgical Teaching Take Time? Resident Participation in Minimally Invasive Hysterectomy for Endometrial Cancer

Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer

Corrigendum to “Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions” [Gynecol. Oncol. 136 (2015) 3–7]

Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system

PIK3CA is implicated as an oncogene in ovarian cancer

Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system

Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations

Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations

Risk management options elected by women after testing positive for a BRCA mutation

Suchergebnisse filtern